Navigating 2026 Benefit Disruptions
40% of patients abandon therapy during coverage changes. This webinar shows how to prevent that.
The stakes are high: As we approach 2026, benefit disruptions are set to impact millions of patients—and your brand’s market access.
Leading pharmaceutical companies are getting ahead of the curve with proactive engagement strategies that turn potential disruptions into competitive advantages. See how in this on-demand webinar hosted by MM+M and featuring expert panelists from Otsuka Precision Health and Timely by DrFirst.
3 key takeaways:
- Eliminate cost barriers before they block access.
- Eliminate prior authorization bottlenecks before they start.
- Build strong patient connections.
Don’t let 2026 benefit changes catch you off guard! Stay ahead of the curve to turn end-of-year transitions into opportunities for sustained success.
Watch now.
Speakers

Sr. Director
Patient Experience Strategy
Otsuka Precision Health

Colin Banas, M.D., M.H.A.
Chief Medical Officer
DrFirst

Caleb Dunn, PharmD
Director of Product Management
DrFirst
“There are a lot of patients who simply don’t understand: What's the availability of the patient support program? How do I actually enroll? What is it going to provide me? And so if we can do that when the prescription is initiated, get in touch with that patient, let them know that there’s someone by their side along this process and we can help guide them and help them navigate this process—that's a reassuring experience.”
Chad Maeder
Sr. Director, Patient Experience Strategy, Otsuka Precision Health

